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Abstract: The high prevalence of bone defects has become a worldwide problem. Despite the
significant amount of research on the subject, the available therapeutic solutions lack efficiency.
Autografts, the most commonly used approaches to treat bone defects, have limitations such as donor
site morbidity, pain and lack of donor site. Marine resources emerge as an attractive alternative
to extract bioactive compounds for further use in bone tissue-engineering approaches. On one
hand they can be isolated from by-products, at low cost, creating value from products that are
considered waste for the fish transformation industry. One the other hand, religious constraints
will be avoided. We isolated two marine origin materials, collagen from shark skin (Prionace
glauca) and calcium phosphates from the teeth of two different shark species (Prionace glauca and
Isurus oxyrinchus), and further proposed to mix them to produce 3D composite structures for hard
tissue applications. Two crosslinking agents, 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide
hydrochloride/N-Hydroxysuccinimide (EDC/NHS) and hexamethylene diisocyanate (HMDI),
were tested to enhance the scaffolds’ properties, with EDC/NHS resulting in better properties.
The characterization of the structures showed that the developed composites could support
attachment and proliferation of osteoblast-like cells. A promising scaffold for the engineering of bone
tissue is thus proposed, based on a strategy of marine by-products valorisation.
Keywords: marine biomaterials; composites; bone tissue engineering; collagen; calcium-phosphates;
shark by-products
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1. Introduction
The regeneration of bone defects represents a growing need and a worldwide concern [1].
Despite the high self-remodelling ability of bone tissue, severe damage can lead to a loss of this innate
capacity. Bone grafts, including, autografts, allografts and xenografts are some of the approaches used
to treat bone defects [2]. However, limitations such as donor site morbidity, pain and lack of donor
site (autografts), and risk of disease transmission or rejection (allografts and xenografts) leave room
for alternative approaches [3]. In that sense, tissue engineering and the development of temporary
regenerative matrices that provide the 3D environment required for cell proliferation and function
promoting tissue growth appears an attractive alternative. While polymers and ceramics have been
largely explored to produce such matrices, reduced biocompatibility and risk of immunogenicity,
respectively, due to synthetic and animal origin components are still observed. Marine resources
emerge as an attractive alternative since they are free of mammalian diseases, or, to date, any other
transmissible disease, and at the same time avoids religious constraints. Moreover, these marine-origin
materials can be isolated from by-products, at low cost, creating value from products that are
considered waste for the fish transformation industry, representing a great opportunity with huge
potential [4–6].
For instance, fish skin and bones have a large amount of bioactive compounds with potential
to be applied in health-related applications [5,7–10], with material properties depending on the raw
material, source and extraction process [11]. Collagen and calcium phosphates represent the most
abundant and explored compounds obtained from fish skin and bones, respectively.
Collagen isolated from salmon fish skin was used to produce 3D composites by a biomimetic
mineralization process [8]. The high potential of these marine origin structures was demonstrated
by the ability of the composites to promote osteogenic differentiation. Moreover, the suitability of
marine origin collagen was also proven by other research groups. Fernandes-Silva and collaborators,
also assessed the excellent properties of marine organisms as a collagen source through the use of
shark collagen to produce hydrogels envisioning cartilage tissue regeneration [12].
Considering the excellent properties of calcium phosphates for hard tissue applications,
recently the potential of bioapatites obtained from teeth of blue shark specie to promote osteogenic
differentiation has been studied [13]. The calcium phosphates isolated from shark tooth are not only
hydroxyapatite (HA), the most commonly used ceramic for hard tissue regeneration, but also HA
enriched with fluorapatite Ca5(PO4)3F, unlike mammalian teeth. Moreover, some other elements,
such as magnesium (Mg) and strontium (Sr), are present in their constitution [13,14]. These ions have
been shown to stimulate osteoblastic activity by different mechanisms [15]. Mg ions, for instance,
are involved in parathyroid hormone regulation, contributing to bone homeostasis [16–19] and fluorine
has been demonstrated to promote bone formation by the stimulation of osteoblastic activity [20,21].
Thus, the presence of such ions in the mixture of the marine bioapatite particles (mBAp) and the
incorporation of such particles into a type I marine collagen (mCol) matrix (the most abundant protein
in hard tissues) can be a perfect combination to ensure good performance in hard tissue applications
using marine origin resources. In that sense, in the present study collagen extracted from the skin
of the blue shark (Prionace glauca) combined with bioceramic particles obtained from tooth of Iurus
oxyrinchus and Prionace glauca were used to produce 3D structures aiming at hard tissue regeneration.
The physical combination of marine bioapatite particles with marine collagen used
to develop the bone-like constructs was tested with two different crosslinking agents,
1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride/N-Hydroxysuccinimide (EDC/NHS)
or hexamethylene diisocyanate (HMDI), at different concentrations, to reinforce the constructs’
stability. The crosslinking approaches are illustrated in Scheme 1. The resulting scaffolds were
characterized, addressing their morphological and mechanical properties, bioactivity upon immersion
in simulated body fluid, cytotoxicity and performance towards bone tissue engineering after the
culture of osteoblast-like cells.
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Scheme 1. Schematic representation of crosslinking reactions for 1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimide hydrochloride (EDC) and hexamethylene diisocyanate (HMDI) crosslinking agents.
2. Results and Discussion
2.1. Physicochemical Properties of Marine Bioapatite (mBAp)
The evaluation of marine bioapatite morphology derived from shark teeth was assessed in a
previous study performed by López-Álvarez and collaborators [14,22].
By X-ray diffraction (XRD) it was possible to observe a combination of 65–70% apatitic phases
(hydroxyapatite and fluorapatite) and 25–30% non-apatitic phases (tricalcium Bis (orthophosphate)
and whitlockite) [23,24]. Morphological characterization by scanning electron microscopy (SEM)
showed particles with a mean pore size of around 50 µm. Through inductively coupled plasma optical
emission spectrometry (ICP-OES) and ion chromatography (Table 1), it was possible to observe that
the main elements present in the marine bioapatite were calcium (Ca) and phosphates (P), followed by
fluorine (F), sodium (Na) and magnesium (Mg). Other elements like strontium (Sr), aluminium (Al),
and iron (Fe) were found in a lower concentration. Comparing this elemental composition with
human bone content, we can see higher concentrations of Ca, P, F and Na ions for marine origin
apatites [25]. These results are in accordance with some other previous studies performed with other
marine organisms like cod fish [26].
Table 1. Elemental composition (% of weight) of bioapatite determined by inductively coupled plasma
optical emission spectrometry (ICP-OES) and ion chromatography analysis.
Element Weight (%)
Ca 44.364 ± 5
P 22.8 ± 2.3
F 1.0 ± 0.5
Na 0.9 ± 0.2
Mg 0.65 ± 0.04
Sr 0.25 ± 0.02
K 0.018 ± 0.002
Al 0.007 ± 0.005
Fe 0.006 ± 0.003
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2.2. Composite Scaffolds’ and Stability
Different composite scaffolds were produced by freeze-drying and crosslinking mixtures of shark
skin collagen and shark teeth bioceramics. Figure 1 illustrates the structures obtained upon crosslinking
with EDC/NHS or HMDI resulting in porous whitish sponges.
Figure 1. Representative composite scaffolds of mCol:mBAp.
The structural stability of the scaffolds, as a measure of the effectiveness of crosslinking reaction
and consecutively the success of the processing methodology, was assessed macroscopically after
incubation in culture medium for 14 days. The results are summarized in Table 2. From the results,
it is clear that there was an increase in the scaffolds’ stability in the presence of mBAp particles
as expected. This result is in agreement with other reports that showed scaffolds with improved
mechanical properties and slower degradation rate when compared with collagen alone, due to the
incorporation of CaP [27]. In terms of crosslinker agents, we can observe similar stability for both
12.5%, 25% of EDC/NHS and 5% HMDI crosslinked scaffolds. Structures crosslinked with 1% HMDI
were completely degraded 1 day after immersion in culture medium at 37 ◦C. This result suggests that
1% of HMDI may not be enough to efficiently crosslink the collagen in the scaffolds.
In general, pore size and porosity decrease as the crosslink concentration increases. In the
case of EDC/NHS, despite the stability results being similar for both concentrations a loss of the
structural integrity for the 25% EDC/NHS formulation was macroscopically observed. These results
were corroborated by SEM images (see Figure 2) which reveal shrinkage of collagen mesh for 25%
EDC/NHS crosslinked scaffolds, with a consequent loss of porosity.
Table 2. Stability of the produced scaffolds after 14 days in culture medium at 37 ◦C. (−) represent
the structures that were completely degraded 1 day after culture medium, (+) structures that were
completely degraded 7 days after incubation (++) structures that maintained integrity 14 days after
culture incubation.
mCol:mBAp 25% EDC/NHS 12.5% EDC/NHS 1% HMDI 5% HMDI
100:0 + − − −
70:30 ++ ++ − ++
50:50 ++ ++ − ++
30:70 ++ ++ − ++
Figure 2. Representative scanning electron microscope (SEM) images of different mCol crosslinked
scaffolds showing the crosslink effect over the microstructure. 25% (A) and 12.5% (B) EDC/NHS
composite scaffolds´ and 5% (C) and 1% HMDI (D) composite scaffolds’.
Mar. Drugs 2018, 16, 269 5 of 14
2.3. Composite Scaffolds’ Morphology
To address the morphological features of the composite scaffolds, microcomputed tomography
(microCT) analysis was performed. A representative example of the 3D composite scaffolds was
selected and shown in Figure 3 according to a colour scale, which was a result of a threshold
applied for the different material densities (considering soft and hard densities for collagen and
ceramic, respectively). A homogenous distribution of mBAp (brown colour) was observed within the
collagen matrix (blue colour) (Figure 3), which suggests an optimized method of scaffolds production,
characterized by a controlled freezing process. Quantitative information of porosity, pore size and
interconnectivity was also obtained from microCT analysis, by modelling the structure with CTAn
software, as depicted in the results outlined in Table 3. In general, for higher concentration of
EDC/NHS and HMDI, 25% and 5%, respectively, a decrease of pore size, porosity and interconnectivity
of pores was observed (Table 3). These results are in accordance with the SEM observation
(Figure 2), which revealed a collagen mesh shrinkage for the higher EDC/NHS and HMDI crosslinker
concentrations. This can be explained by a decrease in the number of free amino groups when
the crosslinkers concentration increases as a result of a more extended crosslinking reaction [28,29].
Trabecular thickness for EDC/NHS conditions is larger as the crosslinker concentration increased,
which was determined by modelling a filling of spheres in the structure by CtAn software. The same
modelling system was used to calculate the interconnectivity, which decreases with the increase of the
crosslinking agent concentration, as described.
Comparing the internal structure of EDC/NHS and HMDI crosslinked scaffolds, in general
microCT results revealed higher pore size, porosity and interconnectivity for the latter ones. This result
suggests a higher efficiency of EDC/NHS to crosslink collagen solutions, leading to the formation
of a more compact structure. The reduced crosslinking effect of HMDI may be due to the unspecific
reaction of isocyanates, which react not only with amine groups but also with hydroxyl groups (OH),
when combined in liquid solutions. This result reveals the importance of using HMDI crosslink
reaction under anhydrous conditions in order to reduce the reactivity of isocyanate with unspecific
hydroxyl groups [25,30]. Taking into account the microCT and stability results, the efficacy of the
scaffolds crosslinked with EDC/NHS at 25% and HMDI at 1% seems to be compromised.
Table 3. Microarchitecture features of the different mCol:mBAp composite scaffolds determined by
microCT analysis.
mCol:mBAp Crosslinker Mean PoreSize (µm) Porosity (%)
Trabecular
Thickness (µm)
Inter-Connectivity
(%)
100:0 25% EDC:NHS 45.5 ± 11.7 48.8 ± 14.8 45.1 ± 8.7 46.4 ± 15.9
100:0 12.5%EDC:NHS 64.1 ± 5.7 72.7 ± 1.8 35.4 ± 5.4 69.3 ± 7.7
100:0 5% HMDI 52.7 ± 11.0 76.3 ± 4.2 27.9 ± 5.5 81.5 ± 8.5
100:0 1% HMDI 115.1 ± 35.6 87.2 ± 1.3 33.2 ± 2.9 69.4 ± 15.1
70:30 25% EDC:NHS 56.5 ± 10.7 48.9 ± 3.4 51.9 ± 4.6 54.3 ± 1.9
70:30 12.5%EDC:NHS 83.4 ± 11.8 78.3 ± 5.7 39.4 ± 1.6 92.1 ± 3.0
70:30 5% HMDI 147.0 ± 38.4 90.4 ± 3.2 41.6 ± 2.7 97.3 ± 1.8
70:30 1% HMDI 161.4 ± 13.7 91.8 ± 2.0 44.4 ± 3.2 97.4 ± 2.1
50:50 25% EDC:NHS 50.5 ± 1.6 49.0 ± 3.1 47.9 ± 2.3 49.8 ± 4.8
50:50 12.5%EDC:NHS 126.3 ± 22.5 85.4 ± 3.2 43.3 ± 0.67 96.8 ± 1.8
50:50 5% HMDI 142.6 + 24.1 89.4 ± 3.0 43.2 ± 2.2 97.4 ± 1.6
50:50 1% HMDI 155.1 ± 31.3 87.8 ± 5.3 46.1 ± 4.6 87.0 ± 11.8
30:70 25% EDC:NHS 113.8 ± 16.0 69.3 ± 1.3 52.8 ± 2.1 65.7 ± 7.9
30:70 12.5%EDC:NHS 104.4 ± 15.7 73.9 ± 1.9 47.0 ± 1.2 85.4 ± 2.4
30:70 5% HMDI 62.6 ± 6.8 67.5 ± 4.2 40.8 ± 1.7 68.8 ± 9.8
30:70 1% HMDI 172.0 ± 43.3 86.8 ± 8.2 46.8 ± 6.0 89.5 ± 9.5
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Figure 3. Representative images of 12.5% EDC/NHS crosslinked scaffolds obtained by microcomputed
tomography (microCT). (A) X-ray 2D projection and respective (B) 3D reconstruction of acquired
structures in which the first column shows a reconstruction of both polymeric and ceramic phases,
and the second column shows the reconstruction of the ceramic phase. A homogeneous distribution
of the materials is observed, according to a colour scale: blue—soft material (mCol); brown—hard
material (mBAp).
In this way, the formulations of 5% HMDI and 12.5% EDC/NHS were chosen to carry on the
study. Assuming a minimum pore size close to 100 µm to promote bone cell adhesion, migration and
proliferation, the range of values obtained for both crosslinking conditions seems to be promising for
cellular studies [31]. Moreover, obtained porosity (around 80%) comprises bone range porosity.
2.4. Composite Scaffolds’ Bioactivity
The SEM images of the composite scaffolds 14 days after incubation in simulated Body Fluid (SBF)
reveal the bioactive nature, i.e., the capacity to induce the mineralization process of the mCol:mBAp
formulations’ structures. Comparing the images before and after SBF (Figure 4), it was possible to
see that there was no mineralization in the collagen structures. In opposition, apatite deposition
occurs in the mCol:mBAp structures and preferentially over the mBAp granules with the characteristic
cauliflower structure. This is in agreement with other studies reporting the difficulty of bone-like
apatite formation through the collagen matrix due to the absence of nucleation sites for apatite growth,
highlighting the relevance of anionic groups as nucleating agents to promote apatite formation [32,33].
Indeed it is well known that the presence of calcium phosphates plays an important function in the
mineralization process [30,34] and phosphate groups can attract calcium ions by electrostatic forces
contributing to apatite formation [32]. In that sense, we can suggest particular interest in using the
combination of mCol with mBAp to induce the mineralization process.
2.5. Mechanical Properties of Composite Scaffolds
The mechanical properties of the developed composite scaffolds were characterized under a
uniaxial compression load by evaluating the compressive elastic modulus. In general, the compressive
modulus results (Figure 5) showed that the presence of mBAp significantly (p < 0.05) and successively
improves scaffolds’ mechanical properties. Interestingly, the effect of bioapatite reinforcement was
more pronounced in the scaffolds crosslinked with HMDI, but independently of the improvements
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the compressive modulus results are considerably lower than those of the trabecular human bone
(100–000 MPa) [35]. Despite the poor mechanical properties of the scaffolds when compared with the
native human bone, all scaffolds present stress–strain curves characteristic of highly ductile materials.
In Figure 6, it is possible to see a representative example of the scaffolds’ mechanical behaviour,
characteristic of flexible foams. This result suggests a high potential of such composites for surgical
handling and fixation to the site of the defect.
Figure 4. Representative scanning electron microscope (SEM) images of the mCol:mBAp composites
scaffolds before and 14 days after the simulated body fluid (SBF) test confirming the bioactive nature of
the formulations as shown by the presence of mineralized deposits.
Figure 5. Compressive modulus of mCol:mBAp scaffolds crosslinked under different conditions. The
Kuskal–Wallis test with Dunn’s multiple comparison test with a p value lower than 0.05 (* p < 0.05)
was considered statistically significant.
Mar. Drugs 2018, 16, 269 8 of 14
Figure 6. Representative example of a stress–strain curve for the mCol:mBAp composite scaffolds.
2.6. Cell Viability in the Composite Scaffolds
In order to guarantee that the processing method did not result in any harmful residual compound,
the metabolic activity of the osteoblast-like cell line (Saos-2) cultured in the scaffolds for 3 days
was assessed.
Comparing the two graphs of the in vitro metabolic activity analysis (Figure 7), we can observe
better results for the 12.5% EDC/NHS crosslinked scaffolds suggesting a higher cytotoxic effect
of HMDI crosslinker. Similar results were achieved within the different mCol:mBAp EDC/NHS
formulations, while for the HMDI crosslinked structures higher variability among the different
formulations was observed.
Figure 7. Metabolic activity of Saos-2 cells cultured in contact with mCol:mBAp scaffolds crosslinked
with (A) 12.5% EDC/NHS and (B) 5% HMDI. Results are the mean ± standard error of three
independent experiments. Statistical analysis was performed using the Kuskal–Wallis test with Dunns
multiple comparison test (* p < 0.05).
Considering both the structural stability and the metabolic activity results, the composite scaffolds
crosslinked with 12.5% EDC/NHS were selected to further proceed with the biological performance
assessment. Live/dead assay was then carried out to complement the MTS assay aiming to confirm
the viability of the cells within the 3D structures and along the culture. Confocal laser scanning
microscopy (CLSM) analysis showed the ability of the scaffolds to support an osteoblast-like cell
culture as demonstrated by the viability of the majority of the cells that are within the structures up to
3 days of culture (Figure 8).
Such results confirm the positive effects of the bioapatite presence on cell biological activity
already demonstrated in previous works [36–38]. In that sense, fish species can be used as a cheap
source to obtain natural calcium phosphates with excellent biological properties.
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From this, the selected composite scaffolds exhibited appropriate properties to be further
considered for bone regeneration strategies, namely to consider their combination with stem cells
promoting differentiation towards the osteogenic lineage.
Figure 8. Saos-2 cell line adhered on 12.5% EDC/NHS composites 24 h after seeding and remains
viable after 72 h. The majority of the cells are viable (green) as demonstrated by the abundant calcein
(AM) stained cells in relation to the propidium iodide (PI) stained dead cells (red).
3. Materials and Methods
3.1. Marine Collagen Extraction
Marine collagen (mCol) was extracted from shark skin (Prionace glauca) by the Instituto de
Investigaciones Marinas (CSIC, Vigo, Spain). About 10 g of skin pieces were first treated with 0.1 N
NaOH (1:10 w/v) by continuous stirring for 24 h at 4 ◦C to remove any non-collagenous protein
present in the skin. Then, the liquid was discarded, and the remaining part was washed several
times to stabilize the pH to 7. The resulting treated skin pieces were further stirred overnight with
10 volumes of 0.5 M acetic acid for the extraction of collagen. The extract was centrifuged at 10.000 g
for 20 min at 10 ◦C. Supernatant was dialyzed withD9402-100FT dialysis membranes from Sigma
with a molecular weight cut-off of 14,000 Da, using cold distilled water with several changes for
24–72 hand freeze-dried. This mCol was characterized as type I collagen by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) as previously described by Sotelo et al. [39].
3.2. Marine Bioapatite Isolation
Marine bioapatite (mBAp) was obtained from shark teeth of Isurus oxyrinchus and Prionace glauca,
provided by the Centro Tecnológico del Mar (CETMAR) and by the fishing company COPEMAR SA
(Porto de Vigo, Spain), respectively. Teeth were cleaned and washed and further dried at 60 ◦C for 24 h.
After this, teeth were ground in a ball mill (Retsch MM2000) for 5 min with an oscillation frequency
between 90 to 100 Hz for powder of 100 to 0.1 µm. This powder of teeth was then pyrolyzed at 950 ◦C
for 12 h with a heating ramp of 2 ◦C/min and a cooling ramp of 20 ◦C/min to remove the organic
material of the tooth. The resulting granules of apatite were separated by sieves into a particle size
between 20 to 63 µm.
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3.3. Physicochemical Characterization
To evaluate the elementary composition of mBAp particles, ICP-OES and ion chromatography
(only measuring fluorine) was carried out (Table 1). Four measurements per condition were taken and
data are represented as mean value in weight percentage (wt %) and with standard deviation.
3.4. Scaffold Production
The 3D composites were produced by an optimized method of freeze-drying. Marine collagen
was combined with marine bioapatite granules using different formulations: mCol:mBAp ratios
of 100:0, 70:30, 50:50, 30:70. The freeze-dried collagen was solubilized at a final concentration of
1.5% in 0.5 M acetic acid followed by dialysis to ensure complete removal of impurities. After that,
the isolated mBAp granules were added in the desired proportion to produce the aforementioned
formulations. EDC/NHS or HMDI, the crosslinking agents selected for the present study, were added
to the mCol:mBAp mixture at 12.5% or 25% for EDC/NHS and 1% or 5% for HMDI. After allowing
the crosslinker to react (24 h), solutions with a viscous appearance were then poured into a mold
and freeze-dried for at least 5 days. To wash out any harmful residual compound all scaffolds were
thoroughly rinsed with distilled water immediately before using in cell culture experiments.
3.5. Stability Assay of 3D Structures
All the characterization studies were performed after sterilization with γ-irradiation (15 kGγ) [40].
The study of the scaffolds’ stability was carried out by incubation in culture medium during 14 days at
37 ◦C. During this period, samples were monitored and photographed to classify them according to
their degree of stability. Samples that degraded 24 h after contact with culture medium at 37 ◦C were
classify as unstable (−). Samples that degrades 7 days after incubation were reported as averagely
stable structures (+) and the ones that maintains their integrity 14 days after culture medium contact
were classify as high stable structures, signal (++).
3.6. Microcomputed Tomography of 3D Structures
Marine bioapatite particles distribution through the collagen matrix was assessed by microCT
in terms of porosity (%), pore size (µm), trabecular thickness (µm) and pore interconnectivity (%,
considering a minimum pore size of 58 µm). For scanning scaffolds (n = 3) a high-resolution microCT
Skyscan 1072 scanner (Skyscan, Kontich, Belgium) with a voltage range and current source between
32–40 kV and 220–248 uA, respectively, was used. Quantitative parameters were measured by
CT-Analyzer software (version 1.12.0.0) from 3D model reconstruction of a representative selection
of slices and a designed region of interest. Thresholds between 30–60 and 120–255 was applied for
the differentiation of soft (mCol) and hard (mBAp particles) materials, respectively. 3D images were
finally obtained by CTvox software resulting in a colour scale directly related to the chosen threshold
according to the material density/hardness.
3.7. Incubation in Simulated Body Fluid (SBS)
To understand the bioactive nature of the composites, SBF with an ion concentration of Na+
142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Cl− 147.8, HCO3− 4.2, HPO43− 1.0 and SO42− 0.5 mM, similar
to the concentration of human blood plasma (Na+ 142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Cl− 103.0,
HCO3− 27, HPO42− 1.0 and SO42− 0.5 mM), was prepared according to Kokubo et al., 2006 [41].
Firstly, the dimensions of the previously produced composites were taken and the volume of SBF
needed to submerse and characterize the bioactivity of those composites was determined through the
following equation:
Vs =
Sa
10
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where Vs is the volume of SBF and Sa correspond to the apparent surface area of each specimen.
For the produced scaffolds, the added volume of SBF was greater than that calculated (Vs), since they
are porous structures. Three replicates of each condition were immersed in the SBF solution at 37 ◦C
and pH 7.4 (mimicking the physiological conditions) for 1, 3, 7 and 14 days. After that, the samples
were removed from the solution and washed with distilled water to avoid the formation of salts during
the drying process. To evaluate apatite formation, samples before and after soaking in SBF were coated
with gold and analysed by scanning electron microscopy (SEM) (JSM-6010LV, JEOL, Tokyo, Japan)
with an acceleration voltage of 15 kV at different magnifications.
3.8. Mechanical Tests of 3D Structures
In order to study the mechanical behaviour of the mCol:mBAp structures, mechanical assays
were carried out under compression mode using an INSTRON 5540. Five replicates of each condition
were tested with a crosshead speed of 2 mm/min and a load cell of 1 kN. The compressive modulus,
a measure of material stiffness was determined from the slope of the linear region of the stress-strain
curve. However, for the formulations crosslinked with 25% of EDC/NHS, this assay was not
determined since they did not present a uniform shape.
3.9. Evaluation of Cell Viability
Aiming at evaluating a potential cytotoxicity effect of the composites, Saos-2 cells were
cultured in the 3D structures. Saos-2 cells were expanded in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum (ALFAGENE, Carcavelos, Portugal) and a 1%
antibiotic–antimycotic (ALFAGENE) mixture. Cells were seeded on top of the different mCol:mBAp
combinations in 48-well plates at a density of 2.5 × 104 cells per scaffold. Metabolic activity at 1 and
3 days after seeding was determined using a 3-(4,5-dimethylthiazol-2-yl)-5-(3 carboxymethoxyphenyl)
2-(4-sulphofenyl)-2H-tetrazolium, inner salt (MTS) (VWR) assay. This assay quantifies the metabolic
activity of the cells by the reduction of tetrazolium salt reagent to formazan after 3 h of incubation
at 37 ◦C. Absorbance intensity, which is directly proportional to metabolic activity, was measured at
492 nm using a microplate reader (SYNERGY HT, BIO-TEK, Winooski, Vermont, USA). The results
are the mean of three independent experiments (n = 3) with 3 replicates for each condition and per
experiment [42].
Cell viability in the 12.5% EDC/NHS crosslinked scaffolds, which showed higher values of
metabolic activity, was also confirmed by staining live/dead cells with calcein (AM)/propidium iodide
(PI) (ALFAGENE), respectively. Briefly, Saos-2 cells were seeded in mCol:mBAp scaffolds, and 1 and
3 days after seeding, the culture medium was removed and replaced by a AM (1:1200) and PI (1:300)
solution in culture medium. After 30 min of incubation in the dark, samples were washed twice with
PBS and immediately visualized by CLSM (TCS SP8, Leica, Wetzlar, Germany). The acquired confocal
images are the scaffolds’ mid-section. The scaffolds were cut in half and analysed according to the
chosen parameters: slice thickness of 3.66 µm, depth of scanning of approximately 120 µm, and no
sequential scanning. Regarding the latter parameter, before each experiment, acquisition conditions
were tested with samples stained with only PI or only AM to ensure no crosstalk would be detected in
the wrong channels.
3.10. Statistical Analysis
Statistical analysis of the results obtained for the different groups of scaffolds at varied conditions
was performed by using Graph Prism Software. Data are presented as the mean ± standard deviation
of a least three independent assays. First, a Shapiro–Wilk test was used to establish the assumption
of data normality. Since data did not follow a normal distribution, a non-parametric test was used
(Kruskal–Wallis test, with Dunn’s multiple comparison test and A p value less than 0.05 (* p < 0.05)
was considered statistically significant.
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4. Conclusions
Marine organisms emerge as an attractive alternative to mammalian ones as raw materials for
the production of biomaterials despite the challenge posed by processing high-quality and low-cost
bioactive compounds from fish waste.
The feasibility of fabricating collagen/apatite scaffolds from by-products of marine resources,
with a homogeneous distribution of apatite particles throughout the collagen matrix, was successfully
accomplished in this work. Despite the scaffolds’ properties being affected by different parameters,
such as the mCol:mBAp ratio and the crosslinker agent, bioactive stable composite structures were
developed. Marine-origin col:BAp scaffolds crosslinked with 12.5% EDC/NHS appear to be suitable
as potential structures for bone regeneration therapeutic approaches. Ongoing work in our lab is
underway to examine their potential to promote osteogenic differentiation.
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